Focus on CaMKII: A molecular switch in the pathophysiology and treatment of mood and anxiety disorders

International Journal of Neuropsychopharmacology

Volumn 7, Issue 3, 2004, Pages 243-248

  Du, Jing ^a   Szabo, Steven T ^a   Gray, Neil A ^a   Manji, Husseini K ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 NITRO 7 SULFAMOYLBENZO[F]QUINOXALINE 2,3 DIONE; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; AMPA RECEPTOR; AMPA RECEPTOR ANTAGONIST; ANTIDEPRESSANT AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; CALCIUM CHANNEL; CALCIUM ION; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DECAHYDRO 6 PHOSPHONOMETHYL 3 ISOQUINOLINECARBOXYLIC ACID; DIZOCILPINE; ENZYME INHIBITOR; FLUVOXAMINE; G PROTEIN COUPLED RECEPTOR; GLUTAMATE RECEPTOR; GLUTAMIC ACID; IONOTROPIC RECEPTOR; KAINIC ACID RECEPTOR; METABOTROPIC RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE 1; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PAROXETINE; PHOSPHODIESTERASE INHIBITOR; PROTEIN BCL 2; PROTEIN KINASE (CALCIUM,CALMODULIN) II; RECEPTOR SUBTYPE; SEROTONIN UPTAKE INHIBITOR;

ANXIETY DISORDER; BRAIN; CENTRAL NERVOUS SYSTEM; DEPRESSION; DRUG TARGETING; ENZYME ACTIVATION; ENZYME INHIBITION; HUMAN; MENTAL DISEASE; MOOD DISORDER; NERVE CELL PLASTICITY; NEUROTRANSMISSION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; PYRAMIDAL NERVE CELL; REVIEW; SIGNAL TRANSDUCTION; STRESS;

ANIMALS; ANTIDEPRESSIVE AGENTS; ANXIETY; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; GLUTAMIC ACID; HUMANS; MOOD DISORDERS; NEURONAL PLASTICITY; SIGNAL TRANSDUCTION;

EID: 4444235081     PISSN: 14611457     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1461145704004432     Document Type: Review

References (22)

1. Bach ME, Hawkins RD, Osman M, Kandel ER, Mayford M (1995). Impairment of spatial but not contextual memory in CaMKII mutant mice with a selective loss of hippocampal LTP in the range of the theta frequency. Cell 81, 905-915.
2. Brocke L, Chiang LW, Wagner PD, Schulman H (1999). Functional implications of the subunit composition of neuronal CaM kinase II. Journal of Biological Chemistry 274, 22713-22722.
3. Charney DS, Manji HK (In Press). Life stress, genes, and depression: multiple pathways lead to increased risk and new opportunities for intervention. Science STKE.
4. Colbran RJ (2004). Targeting of calcium/calmodulin-dependent protein kinase II. Biochemical Journal 378, 1-16.
5. 2+/calmodulin- kinase II enhances channel conductance of alpha-amino-3-hydroxy-5-methyl-4- isoxazolepropionate type glutamate receptors. Proceedings of the National Academy of Sciences USA 96, 3269-3274.
6. Du J, Quiroz JA, Gray NA, Szabo ST, Zarate JCA, Manji HK (In Press). Regulation of cellular plasticity and resilience by mood stabilizers: the role of AMPA receptor trafficking. Dialogues in Clinical Neuroscience.
7. Fink CC, Bayer KU, Myers JW, Ferrell Jr. JE, Schulman H, Meyer T (2003). Selective regulation of neurite extension and synapse formation by the beta but not the alpha isoform of CaMKII. Neuron 17, 283-297.
8. Fink CC, Meyer T (2002). Molecular mechanisms of CaMKII activation in neuronal plasticity. Current Opinion in Neurobiology 12, 293-299.
9. Hayashi Y, Shi SH, Esteban JA, Piccini A, Poncer JC, Malinow R (2000). Driving AMPA receptors into synapses by LTP and CaMKII: requirement for GluR1 and PDZ domain interaction. Science 287, 2262-2267.
10. Kaufman J, Charney D (2000). Comorbidity of mood and anxiety disorders. Depression and Anxiety 12 (Suppl. 1), 69-76.
11. Lisman JE, McIntyre CC (2001). Synaptic plasticity: a molecular memory switch. Current Biology 11, R788-R791.
12. Manji HK, Drevets WC, Charney DS (2001). The cellular neurobiology of depression. Nature Medicine 7, 541-547.
13. McEwen BS (2003). Mood disorders and allostatic load. Biological Psychiatry 54, 200-207.
14. McEwen BS, Magarinos AM (2001). Stress and hippocampal plasticity: implications for the pathophysiology of affective disorders. Human Psychopharmacology 16, S7-S19.
15. Molnar M, Potkin SG, Bunney WE, Jones EG (2003). MRNA expression patterns and distribution of white matter neurons in dorsolateral prefrontal cortex of depressed patients differ from those in schizophrenia patients. Biological Psychiatry 53, 39-47.
16. Popoli M, Gennarelli M, Racagni G (2002). Modulation of synaptic plasticity by stress and antidepressants. Bipolar Disorder 4, 166-182.
17. Sapolsky RM (2000). Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Archives of General Psychiatry 57, 925-935.
18. Shekhar A, Sajdyk TJ, Gehlert DR, Rainnie DG (2003). The amygdala, panic disorder, and cardiovascular responses. Annals of the New York Academy of Sciences 985, 308-325.
19. Suenaga T, Morinobu S, Kawano K, Sawada T, Yamawaki S (2004). Influence of immobilization stress on the levels of CaMKII and phospho-CaMKII in the rat hippocampus. International Journal of Neuropsychopharmacology 7, 000-000.
20. Szabo ST, Gould TD, Manji HK (2003). Neurotransmitters, receptors, signal transduction, and second messengers in psychiatric disorders. In: Nemeroff CB (Ed.), The American Psychiatric Publishing Textbook of Psychopharmacology (pp. 3-52). Arlington: American Psychiatric Publishing Inc.
21. Thiagarajan TC, Piedras-Renteria ES, Tsien RW (2002). Alpha- and betaCaMKII. Inverse regulation by neuronal activity and opposing effects on synaptic strength. Neuron 36, 1103-1114.
22. Xing G, Russell S, Hough C, O'Grady J, Zhang L, Yang S, Zhang LX, Post R (2002). Decreased prefrontal CaMKII alpha mRNA in bipolar illness. Neuroreport 13, 501-505.